You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 19, 2024

Deferoxamine mesylate - Generic Drug Details

✉ Email this page to a colleague

« Back to Dashboard

What are the generic drug sources for deferoxamine mesylate and what is the scope of patent protection?

Deferoxamine mesylate is the generic ingredient in two branded drugs marketed by Dr Reddys, Fresenius Kabi Usa, Gland Pharma Ltd, Hospira, West-ward Pharms Int, and Novartis, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for deferoxamine mesylate. Six suppliers are listed for this compound.

Drug Prices for deferoxamine mesylate

See drug prices for deferoxamine mesylate

Recent Clinical Trials for deferoxamine mesylate

Identify potential brand extensions & 505(b)(2) entrants

Aditya S. Pandey, MDPhase 2
Michigan Medicine PKUHSC Joint Institute for Translational & Clinical ResearchPhase 2
Beijing Pinggu District HospitalPhase 1/Phase 2

See all deferoxamine mesylate clinical trials

Pharmacology for deferoxamine mesylate
Drug ClassIron Chelator
Mechanism of ActionIron Chelating Activity
Medical Subject Heading (MeSH) Categories for deferoxamine mesylate
Anatomical Therapeutic Chemical (ATC) Classes for deferoxamine mesylate

US Patents and Regulatory Information for deferoxamine mesylate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira DEFEROXAMINE MESYLATE deferoxamine mesylate INJECTABLE;INJECTION 076019-002 Mar 17, 2004 AP RX No Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Gland Pharma Ltd DEFEROXAMINE MESYLATE deferoxamine mesylate INJECTABLE;INJECTION 207384-001 Sep 29, 2017 AP RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
West-ward Pharms Int DEFEROXAMINE MESYLATE deferoxamine mesylate INJECTABLE;INJECTION 078086-001 May 30, 2007 AP RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Novartis DESFERAL deferoxamine mesylate INJECTABLE;INJECTION 016267-001 Approved Prior to Jan 1, 1982 AP RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Fresenius Kabi Usa DEFEROXAMINE MESYLATE deferoxamine mesylate INJECTABLE;INJECTION 078718-001 Sep 15, 2009 AP RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.